BD launches new knife range

Article

The BD range of Atomic Edge Limbal Relaxing Incision (LRI) knives for surgical correction of astigmatism has been launched by BD Medical. The knives, which feature a retractable safety shield, use single-crystal silicon, offering high performance at low cost.

The BD range of Atomic Edge Limbal Relaxing Incision (LRI) knives for surgical correction of astigmatism has been launched by BD Medical. The knives, which feature a retractable safety shield, use single-crystal silicon, offering high performance at low cost.

A study conducted in 2007 compared the single-use BD Atomic Edge LRI knives with a single-use metal LRI blade and a reusable diamond LRI blade. Across the five metrics evaluated (incision smoothness, corneal curvature tracking, incision control, incision quality and blade sharpness), the Atomic Edge blade performed better than the single-use metal blade, and equally as well as the reusable diamond blade. The blades were deemed “clinically acceptable” by 95% of the 65 ophthalmic surgeons surveyed.

The BD Atomic Edge LRI knives are available now.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.